default author photo

Paul Armistead

University of North Carolina (UNC) at Chapel Hill

SCHOLARLY PAPERS

1

DOWNLOADS

91

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Safety and Efficacy of CD30.CAR-T Cells as Consolidation Post Autologous Transplant in High-Risk CD30 Lymphoma

Number of pages: 20 Posted: 12 Jan 2024
University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill - Department of Biostatistics, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, Wake Forest University - Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill and University of North Carolina (UNC) at Chapel Hill
Downloads 91 (736,406)

Abstract:

Loading...

CAR-T cells, Hodgkin lymphoma, autologous stem cell transplantation, T-cell lymphoma